Logo image
Sign in
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52
Journal article

Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52

J. N. Ingle, V. J. Suman, James A. Mailliard, J. W. Kugler, J. E. Krook, J. C. Michalak, T. M. Pisansky, L. E. Wold, J. H. Donohue, M. P. Goetz, …
Breast Cancer Research and Treatment, Vol.98(2), pp.217-222
07/2006
PMID: 16538529

Metrics

4 Record Views

Details